(CB) Chubb - Overview
Sector: Financial Services | Industry: Insurance - Property & Casualty | Exchange: NYSE (USA) | Market Cap: 124.150m USD | Total Return: 13.6% in 12m
Industry Rotation: +11.5
Avg Turnover: 520M
EPS Trend: 74.7%
Qual. Beats: 0
Rev. Trend: 88.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Chubb Limited (CB) is a global provider of insurance and reinsurance products, operating through six primary segments including North America Commercial, Personal, Agricultural, Overseas General, Global Reinsurance, and Life Insurance. Headquartered in Zurich, the company maintains a diverse portfolio ranging from traditional property and casualty coverage to specialized lines such as cyber, marine, and crop insurance.
As a leader in the Property & Casualty sector, Chubb utilizes a multi-channel distribution model that leverages independent agents, brokers, and direct-to-consumer platforms. The company’s business model emphasizes underwriting discipline and risk diversification, which is critical in an industry where profitability is heavily influenced by the combined ratio-a measure of incurred losses and expenses relative to earned premiums.
For a more granular look at these financial metrics, consider exploring the data on ValueRay.
The firm also provides comprehensive life insurance and reinsurance solutions, including protection, savings, and annuities. Formerly known as ACE Limited, the company adopted the Chubb name in 2016 following a major acquisition, solidifying its position as one of the world’s largest publicly traded property and casualty insurers by market capitalization.
- Commercial premium pricing trends drive underwriting profitability and net interest income
- Elevated catastrophe loss activity impacts quarterly combined ratios and earnings stability
- Expansion into Asian life insurance markets diversifies long-term revenue streams
- Fixed income portfolio yields fluctuate based on Federal Reserve interest rate policy
- Agricultural insurance margins depend on weather patterns and federal crop subsidy levels
| Net Income: 11.30b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.00 > 1.0 |
| NWC/Revenue: 139.9% < 20% (prev 25.72%; Δ 114.2% < -1%) |
| CFO/TA 0.06 > 3% & CFO 15.90b > Net Income 11.30b |
| Net Debt (14.84b) to EBITDA (12.39b): 1.20 < 3 |
| Current Ratio: 58.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (394.6m) vs 12m ago -2.50% < -2% |
| Gross Margin: 35.20% > 18% (prev 0.27%; Δ 3.49k% > 0.5%) |
| Asset Turnover: 23.20% > 50% (prev 22.48%; Δ 0.71% > 0%) |
| Interest Coverage Ratio: 19.40 > 6 (EBITDA TTM 12.39b / Interest Expense TTM 781.0m) |
| A: 0.31 (Total Current Assets 87.03b - Total Current Liabilities 1.50b) / Total Assets 275.46b |
| B: 0.25 (Retained Earnings 68.82b / Total Assets 275.46b) |
| C: 0.06 (EBIT TTM 15.15b / Avg Total Assets 263.60b) |
| D: 0.32 (Book Value of Equity 63.13b / Total Liabilities 195.54b) |
| Altman-Z'' Score: 3.58 = A |
| DSRI: 0.44 (Receivables 17.10b/35.64b, Revenue 61.15b/56.60b) |
| GMI: 0.77 (GM 35.20% / 26.94%) |
| AQI: 0.71 (AQ_t 0.67 / AQ_t-1 0.93) |
| SGI: 1.08 (Revenue 61.15b / 56.60b) |
| TATA: -0.02 (NI 11.30b - CFO 15.90b) / TA 275.46b) |
| Beneish M-Score: -3.83 (Cap -4..+1) = AAA |
Over the past week, the price has changed by +3.14%, over one month by +0.10%, over three months by +0.61% and over the past year by +13.59%.
- StrongBuy: 4
- Buy: 5
- Hold: 10
- Sell: 3
- StrongSell: 0
| Analysts Target Price | 345.3 | 4.5% |
P/E Forward = 11.8064
P/S = 2.0356
P/B = 1.6802
P/EG = 2.8114
Revenue TTM = 61.15b USD
EBIT TTM = 15.15b USD
EBITDA TTM = 12.39b USD
Long Term Debt = 15.97b USD (from longTermDebt, last quarter)
Short Term Debt = 1.50b USD (from shortTermDebt, last quarter)
Debt = 17.47b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 14.84b USD (from netDebt column, last quarter)
Enterprise Value = 138.99b USD (124.15b + Debt 17.47b - CCE 2.63b)
Interest Coverage Ratio = 19.40 (Ebit TTM 15.15b / Interest Expense TTM 781.0m)
EV/FCF = 8.74x (Enterprise Value 138.99b / FCF TTM 15.90b)
FCF Yield = 11.44% (FCF TTM 15.90b / Enterprise Value 138.99b)
FCF Margin = 26.00% (FCF TTM 15.90b / Revenue TTM 61.15b)
Net Margin = 18.48% (Net Income TTM 11.30b / Revenue TTM 61.15b)
Gross Margin = 35.20% ((Revenue TTM 61.15b - Cost of Revenue TTM 39.62b) / Revenue TTM)
Gross Margin QoQ = 46.37% (prev 32.37%)
Tobins Q-Ratio = 0.50 (Enterprise Value 138.99b / Total Assets 275.46b)
Interest Expense / Debt = 1.13% (Interest Expense 198.0m / Debt 17.47b)
Taxrate = 21.58% (646.0m / 2.99b)
NOPAT = 11.88b (EBIT 15.15b * (1 - 21.58%))
Current Ratio = 58.02 (Total Current Assets 87.03b / Total Current Liabilities 1.50b)
Debt / Equity = 0.24 (Debt 17.47b / totalStockholderEquity, last quarter 73.79b)
Debt / EBITDA = 1.20 (Net Debt 14.84b / EBITDA 12.39b)
Debt / FCF = 0.93 (Net Debt 14.84b / FCF TTM 15.90b)
Total Stockholder Equity = 72.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.29% (Net Income 11.30b / Total Assets 275.46b)
RoE = 15.65% (Net Income TTM 11.30b / Total Stockholder Equity 72.20b)
RoCE = 17.19% (EBIT 15.15b / Capital Employed (Equity 72.20b + L.T.Debt 15.97b))
RoIC = 13.36% (NOPAT 11.88b / Invested Capital 88.92b)
WACC = 5.40% (E(124.15b)/V(141.62b) * Re(6.03%) + D(17.47b)/V(141.62b) * Rd(1.13%) * (1-Tc(0.22)))
Discount Rate = 6.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -82.22 | Cagr: -1.76%
[DCF] Terminal Value 87.14% ; FCFF base≈15.35b ; Y1≈16.71b ; Y5≈20.99b
[DCF] Fair Price = 1.56k (EV 618.04b - Net Debt 14.84b = Equity 603.21b / Shares 387.9m; r=6.0% [WACC]; 5y FCF grow 10.04% → 3.0% )
EPS Correlation: 74.73 | EPS CAGR: 13.80% | SUE: 0.52 | # QB: 0
Revenue Correlation: 87.96 | Revenue CAGR: 11.19% | SUE: 0.75 | # QB: 0
EPS current Quarter (2026-06-30): EPS=6.68 | Chg30d=+0.30% | Revisions=+13% | Analysts=22
EPS next Quarter (2026-09-30): EPS=6.28 | Chg30d=+1.35% | Revisions=+43% | Analysts=22
EPS current Year (2026-12-31): EPS=27.09 | Chg30d=+0.86% | Revisions=+48% | GrowthEPS=+9.3% | GrowthRev=+5.1%
EPS next Year (2027-12-31): EPS=29.23 | Chg30d=+0.39% | Revisions=+36% | GrowthEPS=+7.9% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +48%